Here's why Lupin stock traded higher today

Mini

Lupin was trading higher on the back of some positive news flows regarding Albuterol and Pegfilgrastim.

Lupin was trading higher on the back of some positive news flows regarding Albuterol and Pegfilgrastim.
There are a couple of news points with regards to Lupin. One of them is that the USFDA has accepted Lupin’s application for the cancer biosimilar Pegfilgrastim.
Separately, data from the US indicates that there is a ramp-up for the Albuterol inhaler for both Cipla as well as for Lupin.
The company is targeting nearly 20 percent market share in Albuterol generic inhaler versus the current market share of nearly 8 percent.
Watch the accompanying video of CNBC-TV18’s Ekta Batra for more details.

Market Movers

CompanyPriceChange%Loss
ONGC120.25 -4.85
Coal India146.40 -5.75
JSW Steel670.60 -25.75
NTPC113.55 -3.85
UPL808.00 -27.05
CompanyPriceChange%Loss
ONGC120.35 -4.65
NTPC113.55 -3.70
M&M784.85 -20.60
Power Grid Corp233.00 -6.70
Nestle17,678.30 -375.20
CompanyPriceChange%Loss
ONGC120.25 -4.85 -3.88
Coal India146.40 -5.75 -3.78
JSW Steel670.60 -25.75 -3.70
NTPC113.55 -3.85 -3.28
UPL808.00 -27.05 -3.24
CompanyPriceChange%Loss
ONGC120.35 -4.65 -3.72
NTPC113.55 -3.70 -3.16
M&M784.85 -20.60 -2.56
Power Grid Corp233.00 -6.70 -2.80
Nestle17,678.30 -375.20 -2.08

Currency

CompanyPriceChng%Chng
Dollar-Rupee73.8600-0.2175-0.29
Euro-Rupee87.8770-0.4200-0.48
Pound-Rupee102.2970-0.9290-0.90
Rupee-100 Yen0.6699-0.0019-0.29